Front. Neurosci., 2023 · DOI: 10.3389/fnins.2023.1181816 · Published: April 21, 2023
Spinal cord injury (SCI) is a major cause of disability worldwide and regenerative medicine offers hope for the development of new therapies for these injuries. SCI can result in the loss of sensory and motor function and can have a profound impact on an individual’s quality of life, affecting not only physical abilities but also emotional and social wellbeing. Recent studies have identified new targets and potential strategies for promoting neuronal regeneration, including the use of stem cell therapy, gene therapy and tissue engineering. Gene editing is another type of gene therapy that shows promise in promoting regeneration in various neurodegenerative disease models. Techniques such as CRISPR-Cas9 and iPSCs can correct genetic mutations that contribute to regeneration or reduce the risk of developing neurodegenerative diseases like Parkinson’s disease and Alzheimer’s disease.
Further research into gene therapy can lead to the development of new treatments for spinal cord injuries and other neurological disorders.
The use of nanoparticles in tissue engineering can enhance regenerative medicine strategies for various pathologies.
Combining different approaches such as stem cell therapy, gene therapy, and biomaterials can maximize the regenerative potential of neuronal regenerative medicine.